Stifel Financial’s Acceleron Pharma XLRN Stock Holding History

Stifel Financial’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,011	Closed	-$1.55M	–	3530
2021 Q3	$1.55M	Sell	9,011 -180	-2%	-$23.5K	﹤0.01%	1755
2021 Q2	$1.15M	Buy	9,191 +590	+7%	+$74.4K	﹤0.01%	1988
2021 Q1	$1.17M	Sell	8,601 -29	-0.3%	-$3.75K	﹤0.01%	1893
2020 Q4	$1.1M	Sell	8,630 -46	-0.5%	-$5.39K	﹤0.01%	1775
2020 Q3	$976K	Buy	8,676 +3,489	+67%	+$347K	﹤0.01%	1653
2020 Q2	$494K	Buy	+5,187	New	+$500K	﹤0.01%	2048

Stifel Financial's XLRN Position: Q4 2021 in Review

Stifel Financial sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,011 shares — an estimated $1.55M sold.

Stifel Financial first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $1.55M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Stifel Financial reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Stifel Financial sold 9,011 Acceleron Pharma shares in Q4 2021, an estimated $1.55M.
Stifel Financial first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
Stifel Financial's Acceleron Pharma position peaked at $1.55M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Stifel Financial's 13F filing for Q4 2021, filed 14 Feb 2022.